Home » Lose weight: Even with weight loss injection 2.0, the excess weight comes back quickly

Lose weight: Even with weight loss injection 2.0, the excess weight comes back quickly

by admin
Lose weight: Even with weight loss injection 2.0, the excess weight comes back quickly

health medications

Even with weight loss injection 2.0, the excess weight comes back quickly

Published on December 14, 2023 | Reading time: 3 minutes

Weight loss injections – here “Ozempic” – are in demand. Now a new preparation is coming onto the market

What: REUTERS

You can listen to our WELT podcasts here

In order to display embedded content, your revocable consent to the transmission and processing of personal data is necessary, as the providers of the embedded content require this consent as third party providers [In diesem Zusammenhang können auch Nutzungsprofile (u.a. auf Basis von Cookie-IDs) gebildet und angereichert werden, auch außerhalb des EWR]. By setting the switch to “on”, you agree to this (revocable at any time). This also includes your consent to the transfer of certain personal data to third countries, including the USA, in accordance with Art. 49 (1) (a) GDPR. You can find more information about this. You can revoke your consent at any time using the switch and privacy at the bottom of the page.

“Mounjaro”, a new generation of weight loss syringes, is coming onto the market. The effect is even better than previous medications. But a study shows a problem for patients if treatment is not received.

The now famous weight loss injections “Ozempic” and “Wegovy” are facing competition. On November 9th, the European Medicines Commission (EMA) recommended the approval of the next generation of drugs. The drug “Mounjaro” comes from the US pharmaceutical company Eli Lilly and, according to all studies, works even better than its predecessors: both for controlling blood sugar and for losing weight.

But now a current study shows: Success only lasts as long as the injections are administered.

See also  German Naval Yards: "None of the 100 billion for the Bundeswehr has arrived here"

The new weight loss products developed to treat diabetes trump each other. While people who are very overweight lose around 15 percent of their original weight with the first generation of weight loss injections, people who use “Mounjaro” lose 20 percent of their kilos. So if you weigh 150 kilograms, you will reduce your weight by 30 kilograms within months.

also read

Misuse of medication

To date, only a few overweight people have been able to achieve such weight loss with the help of stomach reductions. While a gastric sleeve often allows you to become permanently slimmer, this does not seem to apply to weight loss injections. As soon as you stop taking them, the weight you lost comes back.

A study in the issue of the specialist magazine “Jama” now confirms these sobering results for the weight loss injection 2.0. The team led by the doctor Louis Aronne from the University of Weill Cornell Medicine in New York administered “Mounjaro” with the active ingredient tirzepatide to almost 700 severely overweight people for nine months. They then separated the group: one half injected the active ingredient of the Eli Lilly preparation, the other half received a placebo.

While the active ingredient group maintained its new lightness, almost all participants in the placebo group had almost completely regained their starting weight after one year. It can even be assumed that it would continue to rise above the initial level, believes Isabelle Mack, head of the nutrition and weight regulation department at the Tübingen University Hospital. The data indicated that the increasing process was far from complete.

See also  Victoria Beckham: With daughter-in-law Nicola at her 50th birthday | Entertainment

also read

Cardiovascular diseases

Struggle with weight

Doctors had great hope for the new weight loss injections. Unlike “Wegovy” and “Ozempic”, whose active ingredient semaglutide suppresses a person’s appetite via the GLP-1 receptor in the brain, “Mounjaro” works via a second pathway. It also binds to so-called GIP receptors, which enhance the effect.

But: “The results are anything but surprising,” says Stephan Martin, diabetologist and director of the West German Diabetes and Health Center in Düsseldorf. With semaglutide there would be almost identical results. And he believes that the increase effect would be even greater in everyday life. “The participants were additionally trained to change their lifestyle.”

In everyday situations, the care is significantly less, so weight gain probably occurs much more quickly. But can you expect a lasting effect after just 36 weeks? The drugs act like psychotherapeutics on brain metabolism. Neurologists assume that this only changes after about two years on average.

Change your lifestyle

Stephan Martin considers this to be unlikely in the case of weight loss injections. “I am more concerned that prolonged use will cause the effect of the medication to wear off,” he says.

He has this experience in practice with people with type 2 diabetes. “Semaglutide works very well in the beginning, but if your lifestyle doesn’t change, the effect wears off.”

Here you will find content from third parties

In order to display embedded content, your revocable consent to the transmission and processing of personal data is necessary, as the providers of the embedded content require this consent as third party providers [In diesem Zusammenhang können auch Nutzungsprofile (u.a. auf Basis von Cookie-IDs) gebildet und angereichert werden, auch außerhalb des EWR]. By setting the switch to “on”, you agree to this (revocable at any time). This also includes your consent to the transfer of certain personal data to third countries, including the USA, in accordance with Art. 49 (1) (a) GDPR. You can find more information about this. You can revoke your consent at any time using the switch and privacy at the bottom of the page.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy